Turn up the chill... Meditation app Calm evolved into a unicorn in February, raising $80M to hit a $1B valuation — now $27M has been tossed in from another venture capital firm. The leader of that firm made clear that she's a power-user — Calm helped her falling-asleep time drop from 30 minutes on average to less than 5 (that's 150 hours more zzzzs per year).
The moment of zen... occurred last year. Calm charges $60/year (or $400 for "Calm for Life") to access its meditative relaxation content. But with competition flowing into mindful apps (think Headspace, Aura, and others), it had to transition from a weekly resolution to a daily habit. So it launched "Sleep Stories" to help you get to your dreams. That's when engagement and retention surged.
You selling a vitamin or aspirin?... It's the key question some VCs ask before they invest. A "vitamin" is nice to have, but not critical. An "aspirin" is something customers need. Now. Both have benefits, but the daily need-to-have option drives engagement and growth. Calm's sleep pivot may have turned it into aspirin, and that's why Lightspeed Ventures says it invested.